Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:COVCVE:LTYNASDAQ:MDNANASDAQ:PDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOV(COV)$0.00$65.97▼$108.57N/AN/A3.88 million shsN/ALTYLiberty BiopharmaC$2.00+∞C$2.00C$0.06▼C$2.74C$21.54MN/A23,286 shs700 shsMDNAMedicenna Therapeutics$0.29$0.15▼$0.84$10.93M1.3160,047 shs1.27 million shsPDPInvesco Dorsey Wright Momentum ETF$106.24+0.1%$100.24$86.41▼$117.67$1.26B1.0221,070 shs9,837 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOV(COV)0.00%0.00%0.00%0.00%0.00%LTYLiberty Biopharma0.00%0.00%0.00%0.00%0.00%MDNAMedicenna Therapeutics0.00%0.00%0.00%0.00%0.00%PDPInvesco Dorsey Wright Momentum ETF+0.11%+1.29%+4.08%+5.95%+11.54%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOV(COV)N/AN/AN/AN/AN/AN/AN/AN/ALTYLiberty BiopharmaN/AN/AN/AN/AN/AN/AN/AN/AMDNAMedicenna TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/APDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOV(COV) 0.00N/AN/AN/ALTYLiberty Biopharma 0.00N/AN/AN/AMDNAMedicenna Therapeutics 3.00Buy$2.50∞ UpsidePDPInvesco Dorsey Wright Momentum ETF 2.67Moderate Buy$106.24N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOV(COV)N/AN/AN/AN/AN/AN/ALTYLiberty BiopharmaN/AN/AC$0.00 per share2,000.00C$0.79 per shareN/AMDNAMedicenna TherapeuticsN/AN/AN/AN/A$0.32 per shareN/APDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOV(COV)N/AN/A0.00N/AN/AN/AN/AN/AN/ALTYLiberty BiopharmaN/A-C$0.16N/A∞N/AN/AN/AN/AN/AMDNAMedicenna Therapeutics-$7.60M-$0.09N/AN/AN/AN/A-42.68%-35.17%N/APDPInvesco Dorsey Wright Momentum ETFN/AN/A28.30∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOV(COV)N/AN/AN/AN/AN/ALTYLiberty BiopharmaN/AN/AN/AN/AN/AMDNAMedicenna TherapeuticsN/AN/AN/AN/AN/APDPInvesco Dorsey Wright Momentum ETF$0.180.17%N/AN/AN/ALatest LTY, MDNA, COV, and PDP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/24/2025PDPInvesco Dorsey Wright Momentum ETF$0.04583/24/20253/24/20253/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOV(COV)N/AN/AN/ALTYLiberty Biopharma8.190.120.12MDNAMedicenna TherapeuticsN/A9.579.57PDPInvesco Dorsey Wright Momentum ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOV(COV)N/ALTYLiberty BiopharmaN/AMDNAMedicenna Therapeutics12.38%PDPInvesco Dorsey Wright Momentum ETFN/AInsider OwnershipCompanyInsider OwnershipCOV(COV)N/ALTYLiberty BiopharmaN/AMDNAMedicenna Therapeutics33.10%PDPInvesco Dorsey Wright Momentum ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOV(COV)N/AN/AN/ANot OptionableLTYLiberty BiopharmaN/A10.77 millionN/ANot OptionableMDNAMedicenna Therapeutics1669.64 million46.59 millionNot OptionablePDPInvesco Dorsey Wright Momentum ETFN/A11.85 millionN/AOptionableLTY, MDNA, COV, and PDP HeadlinesRecent News About These CompaniesHigh-Beta & Momentum ETFs to Play on Hints of Easing Trade Tensions?April 23, 2025 | zacks.comETFs For The Brave: Are These High-Octane Funds Your Best Bet To Ride An Upward Market Swing?April 15, 2025 | benzinga.comBuy High Beta & High Momentum ETFs for Near-Term GainsApril 10, 2025 | zacks.comBuy High Beta & High Momentum ETFs for Near-Term GainsApril 10, 2025 | zacks.comInvesco Exchange-Traded Fund Trust Invesco Dorsey Wright Momentum ETFMarch 25, 2025 | fxempire.comPIZ Invesco Dorsey Wright Developed Markets Momentum ETFNovember 22, 2024 | seekingalpha.comPDP, TRGP, WRB, TDG: Large Inflows Detected at ETFOctober 3, 2024 | nasdaq.com(PDP) Investment AnalysisSeptember 17, 2024 | news.stocktradersdaily.comPDP Invesco Dorsey Wright Momentum ETFAugust 28, 2024 | seekingalpha.comTime for Momentum ETFs?August 20, 2024 | zacks.comMomentum ETFs to Play as Wall Street Rallies?August 16, 2024 | zacks.comInvesco Dorsey Wright Momentum ETF (PDP)November 28, 2023 | finance.yahoo.comInvesco DWA Developed Markets Momentum ETF (PIZ)August 18, 2023 | investing.comInvesco DWA Emerging Markets Momentum ETFJune 30, 2023 | thestreet.comIs Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?February 24, 2023 | msn.comGTO Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Total Return Bond ETFFebruary 23, 2023 | seekingalpha.comInvesco DWA Consumer Cyclicals Momentum ETF (PEZ)December 25, 2022 | finance.yahoo.comPEZ Invesco Exchange-Traded Fund Trust - Invesco DWA Consumer Cyclicals Momentum ETFOctober 11, 2022 | seekingalpha.comInvesco DWA Momentum ETF declares quarterly distribution of $0.0830September 22, 2022 | seekingalpha.comInvesco DWA Momentum ETF declares quarterly distribution of $0.0237June 21, 2022 | seekingalpha.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Beaten-Down Stocks Trading 50% Below Their 52-Week HighsBy Leo Miller | May 27, 2025View 3 Beaten-Down Stocks Trading 50% Below Their 52-Week HighsNear 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a LookBy Chris Markoch | May 31, 2025View Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look3 Top-Rated Energy Companies Staging Strong RecoveriesBy Nathan Reiff | June 2, 2025View 3 Top-Rated Energy Companies Staging Strong Recoveries3 Companies to Buy on This Early Cycle RecoveryBy Gabriel Osorio-Mazilli | June 3, 2025View 3 Companies to Buy on This Early Cycle RecoveryBest Biotech Stocks to Buy in 2025By Dan Schmidt | May 13, 2025View Best Biotech Stocks to Buy in 2025LTY, MDNA, COV, and PDP Company Descriptions(COV) NYSE:COVCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.Liberty Biopharma CVE:LTYC$2.00 +2.00 (+∞) As of 10/10/2018Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.Medicenna Therapeutics NASDAQ:MDNAMedicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.Invesco Dorsey Wright Momentum ETF NASDAQ:PDP$106.24 +0.08 (+0.08%) As of 06/4/2025 03:59 PM EasternPowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Robinhood Stock Keeps Giving Investors Reasons To Buy CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Intuit's AI Boom: Stock Soaring, But Should Investors Hit Pause? Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Analog Devices' Cyclical Recovery Story Has Just Begun Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
